What causes itch in atopic dermatitis?
暂无分享,去创建一个
[1] R. Paus,et al. TRP channels as novel players in the pathogenesis and therapy of itch. , 2007, Biochimica et biophysica acta.
[2] Steve Davidson,et al. The Itch-Producing Agents Histamine and Cowhage Activate Separate Populations of Primate Spinothalamic Tract Neurons , 2007, The Journal of Neuroscience.
[3] V. Rogiers,et al. Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity. , 2005, The Journal of investigative dermatology.
[4] R. Coghill,et al. Repetitive scratching and noxious heat do not inhibit histamine‐induced itch in atopic dermatitis , 2007, The British journal of dermatology.
[5] J. Rees,et al. Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in BalbC mice , 2004, British journal of pharmacology.
[6] H. Maibach,et al. Time-dependent variations of the skin barrier function in humans: transepidermal water loss, stratum corneum hydration, skin surface pH, and skin temperature. , 1998, The Journal of investigative dermatology.
[7] Paul J. Smith,et al. Principal Components Representation of the Two-Dimensional Coronal Tongue Surface , 2002, Phonetica.
[8] G. Yosipovitch,et al. Nocturnal itch: why do we itch at night? , 2007, Acta dermato-venereologica.
[9] M. Boguniewicz. Atopic dermatitis: beyond the itch that rashes. , 2005, Immunology and allergy clinics of North America.
[10] Thomas A. Luger,et al. Proteinase-Activated Receptor-2 Mediates Itch: A Novel Pathway for Pruritus in Human Skin , 2003, The Journal of Neuroscience.
[11] M. Schmelz,et al. Prostaglandin E2 induces vasodilation and pruritus, but no protein extravasation in atopic dermatitis and controls. , 2002, Journal of the American Academy of Dermatology.
[12] H. Stammer,et al. Treatment of pruritus with topically applied opiate receptor antagonist. , 2007, Journal of the American Academy of Dermatology.
[13] M. Akiyama,et al. Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis. , 2008, American journal of human genetics.
[14] M. Steinhoff,et al. Pathophysiology of pruritus in atopic dermatitis: an overview , 2002, Experimental dermatology.
[15] H. Handwerker,et al. Histamine-induced itch and alloknesis (itchy skin) in atopic eczema patients and controls. , 1995, Acta dermato-venereologica.
[16] R. Coghill,et al. Scratching and noxious heat stimuli inhibit itch in humans: a psychophysical study , 2007, The British journal of dermatology.
[17] J. Salomon,et al. The role of selected neuropeptides in pathogenesis of atopic dermatitis , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.
[18] Francis McGlone,et al. Itch : Basic Mechanisms and Therapy , 2004 .
[19] M. Steinhoff,et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. , 2006, The Journal of allergy and clinical immunology.
[20] M. Steinhoff,et al. The neurobiology of itch , 2006, Nature Reviews Neuroscience.
[21] Hermann O. Handwerker,et al. Specific C-Receptors for Itch in Human Skin , 1997, The Journal of Neuroscience.
[22] H. Korting,et al. The pH of the Skin Surface and Its Impact on the Barrier Function , 2006, Skin Pharmacology and Physiology.
[23] Matthias Ringkamp,et al. Psychophysical and Physiological Evidence for Parallel Afferent Pathways Mediating the Sensation of Itch , 2007, The Journal of Neuroscience.
[24] P. Desai,et al. Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. , 2007, The Journal of allergy and clinical immunology.
[25] R. Paus,et al. Frontiers in pruritus research: scratching the brain for more effective itch therapy. , 2006, The Journal of clinical investigation.
[26] P. Klein,et al. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. , 1999, Archives of dermatology.
[27] M. Steinhoff,et al. Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases. , 2008, The Journal of investigative dermatology.
[28] K. Takamori,et al. Possible roles of epidermal opioid systems in pruritus of atopic dermatitis. , 2007, The Journal of investigative dermatology.
[29] Robert C Coghill,et al. The brain processing of scratching. , 2008, The Journal of investigative dermatology.
[30] M. Schmelz,et al. Bradykinin is a potent pruritogen in atopic dermatitis: A switch from pain to itch , 2006, Pain.
[31] H. Akiyama,et al. Psychological Stress can Trigger Atopic Dermatitis in NC/Nga Mice: An Inhibitory Effect of Corticotropin-Releasing Factor , 2008, Neuropsychopharmacology.
[32] A. Slominski. A nervous breakdown in the skin: stress and the epidermal barrier. , 2007, The Journal of clinical investigation.
[33] T. Makino,et al. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis , 2002, The British journal of dermatology.
[34] M. Mihara,et al. Cutaneous nerves in atopic dermatitis , 1998, Virchows Archiv.
[35] M. Schmelz,et al. Influence of vagus nerve stimulation on histamine-induced itching , 2002, Neurology.
[36] G. Yosipovitch. The pruritus receptor unit: a target for novel therapies. , 2007, The Journal of investigative dermatology.
[37] A. Naukkarinen,et al. Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema , 2003, Archives of Dermatological Research.
[38] G. Yosipovitch. Dry skin and impairment of barrier function associated with itch – new insights , 2004, International journal of cosmetic science.
[39] H. Yu,et al. Transepidermal water loss, serum IgE and β‐endorphin as important and independent biological markers for development of itch intensity in atopic dermatitis , 2006, The British journal of dermatology.
[40] M. Graeber,et al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis , 2001, Experimental dermatology.
[41] H. Renz,et al. Brain-derived neurotrophic factor is increased in atopic dermatitis and modulates eosinophil functions compared with that seen in nonatopic subjects. , 2005, The Journal of allergy and clinical immunology.
[42] S. Nakaike,et al. Putative mechanism of the itch-scratch circle: repeated scratching decreases the cutaneous level of prostaglandin D2, a mediator that inhibits itching. , 2007, Prostaglandins, leukotrienes, and essential fatty acids.
[43] S. Hunt,et al. Further exploring the brain-skin connection: stress worsens dermatitis via substance P-dependent neurogenic inflammation in mice. , 2008, The Journal of investigative dermatology.
[44] R. LaMotte,et al. Psychophysical studies of the itch sensation and itchy skin ("alloknesis") produced by intracutaneous injection of histamine. , 1991, Somatosensory & motor research.
[45] H. Nojima,et al. Thromboxane A2 induces itch-associated responses through TP receptors in the skin in mice. , 2007, The Journal of investigative dermatology.
[46] Colin N A Palmer,et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis , 2006, Nature Genetics.
[47] R. Rukwied,et al. Administration of acetylcholine and vasoactive intestinal polypeptide to atopic eczema patients , 1999, Experimental dermatology.
[48] Irene Tracey,et al. Itch and motivation to scratch: an investigation of the central and peripheral correlates of allergen- and histamine-induced itch in humans. , 2007, Journal of neurophysiology.
[49] M. Steinhoff,et al. Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. , 2006, The Journal of investigative dermatology.